Healthequity Inc’s recently made public that its Former Director Kessler Jon unloaded Company’s shares for reported $15.04 million on Jun 06 ’25. In the deal valued at $112.08 per share,134,183 shares were sold. As a result of this transaction, Kessler Jon now holds 253,510 shares worth roughly $26.56 million.
Then, Kessler Jon sold 97,767 shares, generating $10,954,322 in total proceeds. Upon selling the shares at $112.05, the Former Director now owns 75,000 shares.
Before that, Rosner Elimelech sold 58,000 shares. Healthequity Inc shares valued at $6,528,434 were divested by the EVP, CHIEF TECHNOLOGY OFFICER at a price of $112.56 per share. As a result of the transaction, Rosner Elimelech now holds 75,689 shares, worth roughly $7.93 million.
A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in late March from “an Outperform” to “a Strong buy”. Mizuho began covering HQY with “an Outperform” recommendation on December 04, 2024. Goldman started covering the stock on November 15, 2024. It rated HQY as “a Neutral”.
Price Performance Review of HQY
On Friday, Healthequity Inc [NASDAQ:HQY] saw its stock jump 0.74% to $104.76. Over the last five days, the stock has lost -6.09%. Healthequity Inc shares have risen nearly 9.18% since the year began. Nevertheless, the stocks have risen 20.54% over the past one year. While a 52-week high of $116.65 was reached on 06/05/25, a 52-week low of $65.01 was recorded on 04/07/25.
Levels Of Support And Resistance For HQY Stock
The 24-hour chart illustrates a support level at 102.77, which if violated will result in even more drops to 100.79. On the upside, there is a resistance level at 106.26. A further resistance level may holdings at 107.77.
How much short interest is there in Healthequity Inc?
A steep rise in short interest was recorded in Healthequity Inc stocks on 2025-05-30, dropping by -0.21 million shares to a total of 5.96 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 6.17 million shares. There was a decline of -3.47%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 04, 2024 when JMP Securities began covering the stock and recommended ‘”a Mkt outperform”‘ rating along with a $101 price target.
